Site Search

... result of tobacco use, according to the American Cancer Society (ACS). Given this, the state’s biggest opportunity to save lives and reduce health care costs would be increasing the price of tobacco products by $1.50 or more per pack of cigarettes.  “North Carolina’s excise tax on ... increase to the tobacco tax would not only lower tobacco-use rates but also have the added benefit of saving the state millions of dollars in health care costs.”   Based on data from the National Vital Statistics System from 2010 to 2014, the lung cancer mortality rate in the 12 ...

... partners are working together to make sure more Minnesotans can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

... Inc. Dr. Whitney Jones is a Gastroenterologist, a former Clinical Professor of Medicine and current adjunct Professor in the School of Public Health and information services at the University of Louisville.  He is a founding member and currently serves as Chair of the Kentucky Colon ... Bio Alliance of Medicine, an organization advocating for the growth of Idaho's biomedical ecosystem, creating a unified voice for biomedical and health research in Idaho.    Krishna C. Alluri - MD Oncologist and Hematologist, St. Luke's Cancer Institute Dr. Krishna C. Alluri is board ... York.  Before joining Oscar, he led various clinical and business development areas at EmblemHealth, Point-of Care Partners, MedImpact Health Care Systems, and Horizon Blue Cross Blue Shield of New Jersey.  Early in his career, he worked at multiple ...

... What is biomarker testing? Biomarker testing helps get the right treatment to the right patient at the right time. Progress in improving health outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to prevent, ... of a patient’s tissue, blood, or fluid biospecimen for the presence of a biomarker. Biomarker testing is increasingly important for cancer care – and for the treatment of other diseases. Thirty-seven of the 62 oncology drugs launched in the past five years require or recommend ... biomarker testing when medically appropriate. Improving access to biomarker testing and thereby access to targeted therapies will help reduce health disparities and improve outcomes for cancer patients. Expanding access to biomarker testing will also increase patient diversity in clinical ...